Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 13:15:1472957.
doi: 10.3389/fimmu.2024.1472957. eCollection 2024.

Case report: A novel JAK3 homozygous variant in a patient with severe combined immunodeficiency and persistent COVID-19

Affiliations
Case Reports

Case report: A novel JAK3 homozygous variant in a patient with severe combined immunodeficiency and persistent COVID-19

Renan Cesar Sbruzzi et al. Front Immunol. .

Abstract

Inborn errors of immunity (IEI) encompass a broad range of disorders with heterogeneous clinical presentations, often leading to challenges in early diagnosis. This study presents a case of a Brazilian patient with a T-B+NK- severe combined immunodeficiency (SCID) diagnosed at the age of 6 months when was admitted to the hospital due to multiple infectious diseases. Despite undergoing hematopoietic stem cell transplantation (HSCT), the patient had recurrent infections, requiring constant hospital care, including IgG infusions and several antibiotic treatments for the following months. One year after HSCT, presenting mixed chimerism, the patient tested positive for SARS-CoV-2 in nasopharyngeal, duodenum, and intestine samples, with persistent positive tests over a six-month period. Whole exome sequencing identified a private homozygous missense variant (c.1202T>C; p.Leu401Pro) in the Janus Kinase 3 (JAK3) gene. This substitution is located in a highly conserved position, and different bioinformatic variant effect predictors classified the variant as damaging. In silico structural analysis suggested that the variant led to increased structural instability, disrupting the hydrophobic interactions within the SH2 domain, thereby influencing the neighboring residues and potentially altering the interaction between JAK3 and gamma chain (γc) intracellular receptors. This study provides evidence for the novel pathogenicity classification of the variant and highlights the importance of the JAK3 and SH2 domain modulating protein function and their contribution to the SCID pathogenesis.

Keywords: JAK3; SCID; case report; inborn errors of immunity; prolonged SARS-CoV-2; whole exome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Brazilian patient with SCID due to JAK3 deficiency. SCID case report findings, patient’s timeline describing relevance events, and related X-ray findings. In (A) Lung hyperinflation signs. Peribronchovascular bundles, especially in the central lung areas, along with faint heterogeneous opacities, primarily in the lower parts of the left lung and upper parts of the right lung. (B) Mild infiltration in the medullary region of the left lung, with no other evidence of pleuropulmonary alteration. (C) Mild thickening of bronchial walls and apparent splenomegaly can be seen. (D) JAK3 gene and protein. JAK3 gene comprises 24 exons (23 coding) that code seven Janus kinase homology domains (JH1-JH7) highlighting JH3 and JH4 together constitute the SH2-like domain, and JH4 domains constitute the FERM domain. (E) Family pedigree. (F) Multisequence alignment colored according to conservation scores, highlighting p.His377 and p.Leu401. (G) Electropherogram showing the variant’s segregation pattern on the kindred (Y= C+T). (H) 3D structure of JAK3 SH2 domain. (I) 3D stick structure of residues under a distance of 4 angstroms of p.Leu401 (left) and p.Pro401 (right).

References

    1. Aranda CS, Gouveia-Pereira MP, Da Silva CJM, Rizzo MCFV, Ishizuka E, De Oliveira EB, et al. . Severe combined immunodeficiency diagnosis and genetic defects. Immunol Rev. (2024) 322:138–47. doi: 10.1111/imr.13310 - DOI - PubMed
    1. Casanova J-L, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. (2012) 36:515–28. doi: 10.1016/j.immuni.2012.03.016 - DOI - PMC - PubMed
    1. Rivers L, Gaspar HB. Severe combined immunodeficiency: Recent developments and guidance on clinical management. Arch Dis Child. (2015) 100:667–72. doi: 10.1136/archdischild-2014-306425 - DOI - PubMed
    1. Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. . Coronavirus disease 2019 in patients with inborn errors of immunity: An international study. J Allergy Clin Immunol. (2021) 147:520–31. doi: 10.1016/j.jaci.2020.09.010 - DOI - PMC - PubMed
    1. Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. . Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. (2020) 183:1901–1912.e9. doi: 10.1016/j.cell.2020.10.049 - DOI - PMC - PubMed

Publication types